Physician profile
Sylvain Sidi
NPI 1700995586
$771.87
in general payments reported to CMS, 2019-2025
10 companies · $20.82 in 2025
The $20.82 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.79 · 2020: $179 · 2021: $130 · 2022: $102 · 2023: $189 · 2024: $71.59 · 2025: $20.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200 · Gift: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.84 |
| Gift | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.80 | 2019-2024 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $137.33 | 2021-2024 | Stelara, Simponi Aria, Simponi |
| Braintree Laboratories, INC. | $81.81 | 2023 | Sutab |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.12 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.09 | 2023 | Entyvio |
| Phathom Pharmaceuticals, INC. | $36.55 | 2024-2025 | Voquezna |
| Mallinckrodt Hospital Products INC. | $26.00 | 2020 | |
| Pentax of America, INC. | $25.98 | 2021 | |
| W. L. Gore & Associates, INC. | $12.49 | 2021 | |
| Ambu INC. | $9.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvain Sidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.